THE INCIDENCE AND POSSIBLE CAUSES OF ATRIAL FIBRILLATION IN HOSPITALIZED PATIENTS DURING 1985–2010
https://doi.org/10.18705/1607-419X-2013-19-2-109-116
Abstract
Objective. To evaluate the incidence and causes of atrial fi brillation in hospitalized patients of therapeutic profi le and to compare the dynamics of these parameters over past 25 years.
Design and methods. We analyzed 14595 medical histories of the faculty therapy clinic of Pavlov St Petersburg State Medical University for the periods from 1985 to 1990 years and from 2005 to 2010 years.
Results. The incidence of atrial fi brillation increased by 1,7 times over the past 25 years. There is a signifi cant increase in the number of patients with atrial fi brillation in combination with co-morbidities: obesity — 1,9 times, essential hypertension — 1,8 times, and type 2 diabetes mellitus — 3-fold increase. The incidence of valvular heart diseases in patients with atrial fi brillation decreased by 1,9 times from 1985 to 2010 year. Statistical signifi cance of differences was assessed by Fisher’s exact test (p < 0,0001).
Conclusion. The number of hospitalized patients with atrial fi brillation signifi cantly increased over the past 25 years. The number of patients with nonvalvular atrial fi brillation signifi cantly increased from 1985 to 2010 year and the number of patients with rheumatic valvular heart disease with atrial fi brillation decreased.
About the Authors
O. V. Listopad
Pavlov St Petersburg State Medical University, St Petersburg
Russian Federation
Russian Federation
Corresponding author: Pavlov St Petersburg State Medical University, the Department of Internal Diseases № 1 with the Course of Endocrinology named after G.F. Lang, 6/8 L. Tolstoy st., St Petersburg, Russia, 197022. E-mail: olga-list.1976@mail.ru (Olga V. Listopad, an Assistant at the Department of Internal Diseases № 1 with the Course of Endocrinology named after G.F. Lang at Pavlov St Petersburg State Medical University).
D. I. Yatsuk
Pavlov St Petersburg State Medical University, St Petersburg
Russian Federation
Russian Federation
E. I. Baranova
Pavlov St Petersburg State Medical University, St Petersburg
Russian Federation
Russian Federation
References
1. Miyasaka Y., Barnes M.E., Gersh B.J. et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implication on the projections for future prevalence // Circulation. — 2006. — Vol. 114, № 2. — P. 119–125.
2. Lloyd-Jones D.M., Wang T.J., Leip E.P. et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study // Circulation. — 2004. — Vol. 110, № 9. — P. 1042–1046.
3. Heeringa J., van der Kuip D.A., Hofman A. et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study // Eur. Heart J. — 2006. — Vol. 27, № 8. — P. 949–953.
4. Camm A.J., Kirchhof P., Lip G.Y. et al. Guidelines for the management of atrial fi brillation: the Task Force for the management of atrial fi brillation of the European Society of Cardiology (ESC) // Eur. Heart J. — 2010. — Vol. 31, № 19. — P. 2369–2429.
5. Hobbs F.D., Fitzmaurice D.A., Mant J. et al. A randomized controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fi brillation in people aged 65 and over. The SAFE study // Health Technol. Assess. — 2005. — Vol. 9, № 40. — P. iii-iv, ix-x, 1–74.
6. Majeed A., Moser K., Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994–1998: analysis of data from the general practice research database // Heart. — 2001. — Vol. 86, № 3. — P. 284–288.
7. Friberg J., Buch P., Scharling H., Gadsbphioll N., Jensen G.B. Rising rates of hospital admissions for atrial fi brillation // Epidemiology. — 2003. — Vol. 14, № 6. — P. 666–672.
8. Сharlemagne A., Blacher J., Cohen A. et al. Epidemiology of atrial fibrillation in France: Extrapolation of international epidemiological data to France and analysis of French hospitalization data // Arch. Cardiovasc. Dis. — 2011. — Vol. 104, № 2. — P. 115–124.
9. Wolowacz S.E., Samuel M., Brennan V.K., Jasso- Mosqueda J.G., Van Gelder I.C. The cost of illness of atrial fibrillation: a systematic review of the recent literature // Europace. — 2011. — Vol. 13, № 10. — Р. 1375–1385.
10. Huxley R.R., Lopez F.L., Folsom A.R. et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study // Circulation. — 2011. — Vol. 123, № 14. — P. 1501–1508.
11. Camm A.J., Lip G.Y., De Caterina R. et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation (ESC) // Eur. Heart J. — 2012. — Vol. 33, № 21. — Р. 2719–2747. doi:10.1093/eurheartj/ehs253.
12. Chamberlain A., Agarwal S., Ambrose M., Folsom A.R., Soliman E.Z., Alonso A. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study // Am. Heart J. — 2010. — Vol. 159, № 5. — Р. 850–856.
13. Wanahita N., Messerli F.H., Bangalore S., Gami A.S., Somers V.K., Steinberg J.S. Atrial fibrillation and obesity — results of a meta-analysis //Am. Heart J. — 2008. — Vol. 155, № 2. — P. 310–315.
Review
For citations:
Listopad O.V., Yatsuk D.I., Baranova E.I. THE INCIDENCE AND POSSIBLE CAUSES OF ATRIAL FIBRILLATION IN HOSPITALIZED PATIENTS DURING 1985–2010. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2013;19(2):109-116. (In Russ.) https://doi.org/10.18705/1607-419X-2013-19-2-109-116
Views:
1199
Email this article 